中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 2
Feb.  2025
Turn off MathJax
Article Contents

Value of internal stratification analysis of abdominal wall muscles in predicting complications after orthotopic liver transplantation

DOI: 10.12449/JCH250218
Research funding:

Science and Technology Development Plan Fund of Jilin Province (20220505017ZP)

More Information
  • Corresponding author: WANG Jiping, jiping@jlu.edu.cn (ORCID: 0000-0003-1991-4104)
  • Received Date: 2024-06-21
  • Accepted Date: 2024-07-26
  • Published Date: 2025-02-25
  •   Objective  To divide the muscle into different subzones according to different density ranges using the stratified analysis on the basis of myosteatosis, and to investigate the effect of muscle density changes on complications (Clavien-Dindo grade ≥Ⅲ) after orthotopic liver transplantation (OLT).  Methods  A retrospective analysis was performed for the medical records of 145 patients who underwent OLT in The First Hospital of Jilin University from May 2013 to September 2020, and with the plain CT scan images of the largest level of lumbar 3 vertebrae of each patient as the original data, Neusoft Fatanalysis software was used to measure related muscle parameters. The independent-samples t test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. The chi-square test or Fisher test was for comparison of categorical data between two groups. RIAS software was used to extract clinical features and perform analysis and modeling, and three machine learning models of logistic regression (LR), support vector machine (SVM), and random forest (RFC) were constructed. The receiver operating characteristic (ROC) curve, the calibration curve, and the decision curve were plotted for each model to calculate the area under the ROC curve (AUC), sensitivity, specificity, precision, F1 score, and accuracy.  Results  The three machine learning models of LR-C, SVM-C, and RFC-C were established based on the 7 clinical features before muscle stratification analysis, among which the RFC-C model had an AUC of 0.803, a sensitivity of 0.588, and a specificity of 0.778 in the test set. Among the models of LR-CS, SVM-CS, and RFC-CS established based on the 16 clinical features after muscle stratification analysis, the LR-CS and SVM-CS models had an AUC of 0.852 in the test set, with a sensitivity of 0.765 and 0.706, respectively, and a specificity of 0.889 and 0.926, respectively. Comparison of the AUC, sensitivity, specificity, precision, F1 score, and accuracy of each model in the test set before and after muscle stratification analysis showed that there were improvements in the parameters of the predictive model after muscle stratification analysis. Comparison of the decision curves and calibration curves of each predictive model showed that the LR-CS and SVM-CS models had good efficacy in predicting postoperative complications (Clavien-Dindo grade≥Ⅲ) in OLT patients.  Conclusion  On the basis of myosteatosis, the division of the muscle into different subzones according to different densities using the stratified analysis has a certain value in predicting postoperative complications in patients with OLT.

     

  • loading
  • [1]
    CORREA-DE-ARAUJO R, ADDISON O, MILJKOVIC I, et al. Myosteatosis in the context of skeletal muscle function deficit: An interdisciplinary workshop at the national institute on aging[J]. Front Physiol, 2020, 11: 963. DOI: 10.3389/fphys.2020.00963.
    [2]
    KOTEISH A, DIEHL AM. Animal models of steatosis[J]. Semin Liver Dis, 2001, 21( 1): 89- 104. DOI: 10.1055/s-2001-12932.
    [3]
    KIRKLAND JL, TCHKONIA T, PIRTSKHALAVA T, et al. Adipogenesis and aging: Does aging make fat go MAD?[J]. Exp Gerontol, 2002, 37( 6): 757- 767. DOI: 10.1016/s0531-5565(02)00014-1.
    [4]
    FARUP J, MADARO L, PURI PL, et al. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease[J]. Cell Death Dis, 2015, 6( 7): e1830. DOI: 10.1038/cddis.2015.198.
    [5]
    SCHRAUWEN-HINDERLING VB, KOOI ME, HESSELINK MC, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects[J]. Diabetologia, 2007, 50( 1): 113- 120. DOI: 10.1007/s00125-006-0475-1.
    [6]
    HIBI T, WEI CHIEH AK, CHAN AC, et al. Current status of liver transplantation in Asia[J]. Int J Surg, 2020, 82S: 4- 8. DOI: 10.1016/j.ijsu.2020.05.071.
    [7]
    KAIDO T. Recent evolution of living donor liver transplantation at Kyoto University: How to achieve a one-year overall survival rate of 99%?[J]. Hepatobiliary Pancreat Dis Int, 2020, 19( 4): 328- 333. DOI: 10.1016/j.hbpd.2020.06.006.
    [8]
    DUTKOWSKI P, OBERKOFLER CE, SLANKAMENAC K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era[J]. Ann Surg, 2011, 254( 5): 745-753; discussion753. DOI: 10.1097/SLA.0b013e3182365081.
    [9]
    BRAAT AE, BLOK JJ, PUTTER H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI[J]. Am J Transplant, 2012, 12( 10): 2789- 2796. DOI: 10.1111/j.1600-6143.2012.04195.x.
    [10]
    RANA A, JIE T, PORUBSKY M, et al. The survival outcomes following liver transplantation(SOFT) score: Validation with contemporaneous data and stratification of high-risk cohorts[J]. Clin Transplant, 2013, 27( 4): 627- 632. DOI: 10.1111/ctr.12181.
    [11]
    POMMERGAARD HC, DAUGAARD TR, ROSTVED AA, et al. Model for end-stage liver disease score predicts complications after liver transplantation[J]. Langenbecks Arch Surg, 2021, 406( 1): 55- 65. DOI: 10.1007/s00423-020-02018-3.
    [12]
    SCHLEGEL A, LINECKER M, KRON P, et al. Risk assessment in high- and low-MELD liver transplantation[J]. Am J Transplant, 2017, 17( 4): 1050- 1063. DOI: 10.1111/ajt.14065.
    [13]
    CZIGANY Z, KRAMP W, BEDNARSCH J, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation[J]. Am J Transplant, 2020, 20( 2): 493- 503. DOI: 10.1111/ajt.15577.
    [14]
    CZIGANY Z, KRAMP W, LURJE I, et al. The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation[J]. J Cachexia Sarcopenia Muscle, 2021, 12( 2): 358- 367. DOI: 10.1002/jcsm.12669.
    [15]
    MEISTER FA, BEDNARSCH J, AMYGDALOS I, et al. Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation[J]. Sci Rep, 2021, 11( 1): 13368. DOI: 10.1038/s41598-021-92798-5.
    [16]
    SHENVI SD, TABER DJ, HARDIE AD, et al. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients[J]. HPB(Oxford), 2020, 22( 1): 102- 108. DOI: 10.1016/j.hpb.2019.06.006.
    [17]
    AHN H, KIM DW, KO Y, et al. Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: A new paradigm beyond sarcopenia[J]. Ageing Res Rev, 2021, 70: 101398. DOI: 10.1016/j.arr.2021.101398.
    [18]
    FARON A, SPRINKART AM, KUETTING DLR, et al. Body composition analysis using CT and MRI: Intra-individual intermodal comparison of muscle mass and myosteatosis[J]. Sci Rep, 2020, 10( 1): 11765. DOI: 10.1038/s41598-020-68797-3.
    [19]
    DINDO D, DEMARTINES N, CLAVIEN PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6 336 patients and results of a survey[J]. Ann Surg, 2004, 240( 2): 205- 213. DOI: 10.1097/01.sla.0000133083.54934.ae.
    [20]
    XU X, YANG JY, ZHONG L, et al. The clinical value of“Hangzhou Criteria” in the selection of patients with hepatocellular carcinoma for liver transplantation: A report of 1 163 cases on a multi-center basis[J]. Chin J Organ Transplant, 2013, 34( 9): 524- 527. DOI: 10.3760/cma.j.issn.0254-1785.2013.09.004.

    徐骁, 杨家印, 钟林, 等. 肝癌肝移植“杭州标准”的多中心应用研究: 1 163例报道[J]. 中华器官移植杂志, 2013, 34( 9): 524- 527. DOI: 10.3760/cma.j.issn.0254-1785.2013.09.004.
    [21]
    MARTIN L, BIRDSELL L, MACDONALD N, et al. Cancer Cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index[J]. J Clin Oncol, 2013, 31( 12): 1539- 1547. DOI: 10.1200/JCO.2012.45.2722.
    [22]
    LI MY, LI XY, GUO Y, et al. Development and assessment of an individualized nomogram to predict colorectal cancer liver metastases[J]. Quant Imaging Med Surg, 2020, 10( 2): 397- 414. DOI: 10.21037/qims.2019.12.16.
    [23]
    van GRIETHUYSEN JJM, FEDOROV A, PARMAR C, et al. Computational radiomics system to decode the radiographic phenotype[J]. Cancer Res, 2017, 77( 21): e104- e107. DOI: 10.1158/0008-5472.CAN-17-0339.
    [24]
    HAMAGUCHI Y, KAIDO T, OKUMURA S, et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation[J]. Liver Transpl, 2014, 20( 11): 1413- 1419. DOI: 10.1002/lt.23970.
    [25]
    HAMAGUCHI Y, KAIDO T, OKUMURA S, et al. Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation[J]. J Cachexia Sarcopenia Muscle, 2018, 9( 2): 246- 254. DOI: 10.1002/jcsm.12276.
    [26]
    ZHUANG CL, SHEN X, HUANG YY, et al. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort[J]. Surgery, 2019, 166( 3): 297- 304. DOI: 10.1016/j.surg.2019.03.020.
    [27]
    KIM DW, KIM KW, KO Y, et al. Assessment of myosteatosis on computed tomography by automatic generation of a muscle quality map using a web-based toolkit: Feasibility study[J]. JMIR Med Inform, 2020, 8( 10): e23049. DOI: 10.2196/23049.
    [28]
    SJØBLOM B, GRØNBERG BH, WENTZEL-LARSEN T, et al. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer[J]. Clin Nutr, 2016, 35( 6): 1386- 1393. DOI: 10.1016/j.clnu.2016.03.010.
    [29]
    BOWDEN JS, WILLIAMS LJ, SIMMS A, et al. Prediction of 90 day and overall survival after chemoradiotherapy for lung cancer: Role of performance status and body composition[J]. Clin Oncol(R Coll Radiol), 2017, 29( 9): 576- 584. DOI: 10.1016/j.clon.2017.06.005.
    [30]
    KUMAR A, MOYNAGH MR, MULTINU F, et al. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer[J]. Gynecol Oncol, 2016, 142( 2): 311- 316. DOI: 10.1016/j.ygyno.2016.05.027.
    [31]
    AUST S, KNOGLER T, PILS D, et al. Skeletal muscle depletion and markers for cancer Cachexia are strong prognostic factors in epithelial ovarian cancer[J]. PLoS One, 2015, 10( 10): e0140403. DOI: 10.1371/journal.pone.0140403.
    [32]
    van RIJSSEN LB, van HUIJGEVOORT NM, COELEN RS, et al. Skeletal muscle quality is associated with worse survival after pancreatoduodenectomy for periampullary, nonpancreatic cancer[J]. Ann Surg Oncol, 2017, 24( 1): 272- 280. DOI: 10.1245/s10434-016-5495-6.
    [33]
    OKUMURA S, KAIDO T, HAMAGUCHI Y, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer[J]. Ann Surg Oncol, 2017, 24( 12): 3732- 3740. DOI: 10.1245/s10434-017-6077-y.
    [34]
    TAMANDL D, PAIREDER M, ASARI R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer[J]. Eur Radiol, 2016, 26( 5): 1359- 1367. DOI: 10.1007/s00330-015-3963-1.
    [35]
    CHU MP, LIEFFERS J, GHOSH S, et al. Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy[J]. J Cachexia Sarcopenia Muscle, 2017, 8( 2): 298- 304. DOI: 10.1002/jcsm.12161.
    [36]
    BOER BC, de GRAAFF F, BRUSSE-KEIZER M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer[J]. Int J Colorectal Dis, 2016, 31( 6): 1117- 1124. DOI: 10.1007/s00384-016-2538-1.
    [37]
    van DIJK DPJ, BAKENS MJAM, COOLSEN MME, et al. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer[J]. J Cachexia Sarcopenia Muscle, 2017, 8( 2): 317- 326. DOI: 10.1002/jcsm.12155.
    [38]
    AKAHORI T, SHO M, KINOSHITA S, et al. Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy[J]. World J Surg, 2015, 39( 12): 2975- 2982. DOI: 10.1007/s00268-015-3205-3.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(7)  / Tables(4)

    Article Metrics

    Article views (543) PDF downloads(26) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return